To Vaccinate or not: Influenza Virus and Lung Cancer Progression.
Antiviral Agents
/ therapeutic use
Disease Progression
Humans
Influenza A virus
/ immunology
Influenza Vaccines
/ administration & dosage
Influenza, Human
/ complications
Lung
/ immunology
Lung Neoplasms
/ complications
Medical Oncology
/ standards
Practice Guidelines as Topic
Tumor Microenvironment
/ immunology
Vaccination
/ standards
cancer patients
influenza virus
lung cancer
vaccination
Journal
Trends in cancer
ISSN: 2405-8025
Titre abrégé: Trends Cancer
Pays: United States
ID NLM: 101665956
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
03
12
2020
revised:
18
02
2021
accepted:
19
02
2021
pubmed:
14
3
2021
medline:
21
12
2021
entrez:
13
3
2021
Statut:
ppublish
Résumé
Influenza virus infection leads to severe and complicated disease, particularly in patients with lung cancer. It alters the tumor microenvironment (TME), which may potentiate lung cancer progression and disrupt responses to antitumoral treatments. Consequently, influenza vaccination and antiviral treatments should be recommended to all patients with lung cancer.
Identifiants
pubmed: 33712391
pii: S2405-8033(21)00061-3
doi: 10.1016/j.trecan.2021.02.006
pii:
doi:
Substances chimiques
Antiviral Agents
0
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
573-576Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests The authors declare that they have no competing interests.